Heath Law Alliance is proud to announce a major legal victory on behalf of its pharmacy client in California: the full reversal of a Medi-Cal (California Medicaid) payment suspension imposed by the California Department of Health Care Services (DHCS).
Medi-Cal payment suspensions are serious administrative actions that can jeopardize a pharmacy’s business operations, reputation, and its ability to service its patients. These payment suspensions are often triggered by preliminary audit findings and/or other unverified suspicions of wrongdoing. In this case, DHCS initiated a payment suspension based on speculative allegations and incomplete evidence.
Heath Law Alliance intervened immediately. Our legal team crafted a number of strategic and persuasive appeals, demonstrating that the Department’s allegations failed to meet the legal standards required under both state and federal law. After a thorough review, the Office of Administrative Hearings and Appeals agreed with our position and issued a decision reversing the payment suspension in full.
This outcome underscores the importance of experienced legal counsel when dealing with Medicaid and/or any other insurance payors. It highlights our firm’s commitment to aggressive advocacy and unwavering defense of healthcare providers’ rights and business operations.
How Health Law Alliance Can Help
If your pharmacy is facing insurance payment suspensions, network terminations, investigations, and/or PBM audits, Heath Law Alliance stands ready to defend your practice and challenge unjust enforcement actions. With extensive experience in healthcare law, Medicaid and Medicare regulations, pharmacy provider defense, and litigation, our law firm is uniquely positioned to safeguard your interests and help secure the future of your pharmacy business.
Contact us today to schedule a free consultation.
MORE ARTICLES BY CATEGORY
California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business
California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.
Read More >>The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.
Read More >>OMIG Audit Defense New York: What the 2026 Work Plan Means for Providers
Every year, the New York Office of the Medicaid Inspector General (OMIG) releases its Work Plan outlining enforcement priorities. The 2026 plan sends a clear signal that Medicaid providers in New York are entering a far more aggressive enforcement environment.
Read More >>PBM Member Denial Audit Findings: A Growing Threat to Pharmacies
Pharmacies undergoing a Pharmacy Benefit Manager (PBM) audit are typically prepared to address inventory discrepancies and documentation issues. What many are not prepared for, however, is the increasing use of PBM member denial findings, allegations that a patient claims they did not receive and/or did not authorize the dispensing of a medication for which a claim was submitted.
Read More >>
